Spero Therapeutics Inc (SPRO) Directors and Executive Officers - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Spero Therapeutics Inc   (NASDAQ: SPRO)

Spero Therapeutics Inc

Officers & Directors


John C. Pottage, M.D.
Director

Scott Jackson
Director

Esther Rajavelu
Chief Financial Officer, Chief Business Officer and Treasurer

Patrick Vink, M.D.
Director

Milind Deshpande, Ph.D.
Director

Frank E. Thomas
Director

Satyavrat Shukla
President, Chief Executive Officer and Director

Cynthia Smith
Director

Ankit Mahadevia, M.D.
Chairman

Kathleen Tregoning
Director


Boston, Massachusetts ,

Spero Therapeutics Inc currently has 25 employees.






SPRO Management Effectiveness SPRO Revenue per Employee SPRO Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.